Algert Global LLC Acquires Shares of 186,190 The Chemours Company (NYSE:CC)

Algert Global LLC purchased a new position in shares of The Chemours Company (NYSE:CC - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 186,190 shares of the specialty chemicals company's stock, valued at approximately $3,147,000. Algert Global LLC owned about 0.12% of Chemours at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the business. Norges Bank acquired a new position in shares of Chemours in the 4th quarter valued at $30,702,000. Bank of Montreal Can raised its holdings in Chemours by 1,496.4% in the 4th quarter. Bank of Montreal Can now owns 953,240 shares of the specialty chemicals company's stock valued at $16,110,000 after buying an additional 893,530 shares during the period. Invesco Ltd. lifted its position in Chemours by 141.5% in the fourth quarter. Invesco Ltd. now owns 1,020,001 shares of the specialty chemicals company's stock valued at $17,238,000 after buying an additional 597,638 shares during the last quarter. Covalis Capital LLP purchased a new position in Chemours during the fourth quarter worth about $8,768,000. Finally, Peregrine Capital Management LLC purchased a new stake in shares of Chemours in the 4th quarter valued at approximately $5,731,000. Hedge funds and other institutional investors own 76.26% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CC. Barclays dropped their price objective on Chemours from $19.00 to $16.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 1st. UBS Group reduced their price target on shares of Chemours from $18.00 to $17.00 and set a "buy" rating on the stock in a research report on Wednesday, May 7th. Royal Bank of Canada lowered their price objective on shares of Chemours from $17.00 to $14.00 and set an "outperform" rating for the company in a research note on Thursday, May 8th. StockNews.com downgraded shares of Chemours from a "hold" rating to a "sell" rating in a research note on Thursday, May 8th. Finally, Morgan Stanley decreased their price target on shares of Chemours from $22.00 to $15.00 and set an "equal weight" rating for the company in a research report on Monday. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, Chemours has an average rating of "Hold" and an average price target of $18.33.

Chemours Stock Performance

Shares of CC stock traded down $0.06 during trading hours on Tuesday, hitting $11.93. The stock had a trading volume of 1,028,171 shares, compared to its average volume of 1,978,798. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92. The firm has a market capitalization of $1.79 billion, a PE ratio of 20.93 and a beta of 1.76. The stock's 50 day moving average is $12.51 and its 200 day moving average is $16.46. The Chemours Company has a twelve month low of $9.33 and a twelve month high of $29.21.

Chemours (NYSE:CC - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). Chemours had a return on equity of 26.54% and a net margin of 1.51%. The business had revenue of $1.37 billion for the quarter, compared to analysts' expectations of $1.36 billion. During the same period in the previous year, the business posted $0.32 earnings per share. The company's revenue for the quarter was up .4% on a year-over-year basis. As a group, research analysts forecast that The Chemours Company will post 2.03 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 8.38%. The ex-dividend date of this dividend was Friday, February 28th. Chemours's dividend payout ratio is presently 175.00%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.